Home Forex Amgen Fourth-Quarter Results Decline on Foreign-Exchange Headwinds, Issues Full-Year Outlook

Amgen Fourth-Quarter Results Decline on Foreign-Exchange Headwinds, Issues Full-Year Outlook

by admin


MT Newswires 2023

All news about AMGEN INC.
08:15a Amgen Fourth-Quarter Results Decline on Foreign-Exchange Headwinds, Issues Full-Year Ou..

MT

08:00a Futures dip on jitters ahead of ADP report, Fed decision

RE

01/31 Amgen : Q4 2022 Earnings Conference Call Transcript

PU

01/31 Amgen posts full transcript and audio replay of fourth quarter and full year 2022 earni..

PR

01/31 Amgen Q4 Non-GAAP Earnings, Revenue Decline, Sets 2023 Guidance In-Line With Estimates

MT

01/31 Amgen 4Q Profit Declines, Revenue Ticks Down Slightly

DJ

01/31 Transcript : Amgen Inc., Q4 2022 Earnings Call, Jan 31, 2023

CI

01/31 Amgen : Q4 Earnings Snapshot

AQ

01/31 Amgen Inc : Entry into a Material Definitive Agreement, Results of Operations and Financia..

AQ

01/31 Amgen Guides For Full Year 2023 EPS of $17.40-$18.60 on Revenue of $26-$27.2 Billion, v..

MT

Analyst Recommendations on AMGEN INC.

Sales 2022 26 247 M

Net income 2022 6 523 M

Net Debt 2022 26 556 M

P/E ratio 2022 20,9x
Yield 2022 3,07%
Capitalization 135 B
135 B
EV / Sales 2022 6,14x
EV / Sales 2023 5,90x
Nbr of Employees 24 200
Free-Float 99,8%



Duration :


Period :




Amgen Inc. Technical Analysis Chart | MarketScreener

Technical analysis trends AMGEN INC.

Short Term Mid-Term Long Term
Trends Bearish Neutral Neutral

Income Statement Evolution

Sell

Buy

Mean consensus HOLD
Number of Analysts 25
Last Close Price 252,40 $
Average target price 263,35 $
Spread / Average Target 4,34%


You may also like

Leave a Comment